Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -44.7% | 103.2% | 34.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 91.7% | 89% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -273.5% | -130.1% | -311.3% | -349.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -268.4% | -131.3% | -220% | -260.9% |
| EPS Diluted | -0.005 | -0.006 | -0.006 | -0.005 |
| % Growth | 18.3% | -5.3% | -7.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |